Monoprost (Latanoprost)

Latanoprost activates prostaglandin F (FP) receptors in the ciliary body, promoting remodeling of the extracellular matrix and increasing uveoscleral outflow of aqueous humor, which reduces intra‑ocular pressure.

The prescribed dose of Monoprost is determined by the treating ophthalmologist. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but exact dosing must follow the prescriber’s instructions.

Safety data for latanoprost in pregnancy and lactation are limited. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the prescriber should evaluate each case individually.

To order Monoprost, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Monoprost (latanoprost) is a prostaglandin analog, generally offering once‑daily dosing and strong intra‑ocular pressure reduction. Compared with beta‑blocker or carbonic anhydrase inhibitor drops, latanoprost often provides greater pressure‑lowering efficacy with a different side‑effect profile, such as increased eyelash growth and iris pigmentation.

Monoprost should be stored at room temperature, below 25 °C, in its original container. Keep the bottle tightly closed, protect it from light and moisture, and discard any solution that appears discolored or contains particles.

Monoprost is applied as a sterile eye‑drop solution. The patient should wash hands, tilt the head back, pull down the lower eyelid to form a pocket, and instill one drop into the prescribed eye(s) without touching the tip to the ocular surface. Close the eye gently for a few seconds after administration.

Serious risks, though rare, include severe allergic reactions, uveitis, macular edema, and paradoxical increase in intra‑ocular pressure. Patients should seek immediate medical attention if they experience sudden eye pain, vision loss, swelling, or systemic allergic symptoms.

Monoprost is contraindicated in patients with known hypersensitivity to latanoprost or any component of the formulation, and it should be used with caution in individuals with active ocular inflammation, recent ocular surgery, or those who are pregnant or breastfeeding without clear benefit.